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Vitamin D3 up-regulated protein-1 regulates collagen
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Vitamin D3 up-regulated protein-1 regulates collagen expres-
sion in mesangial cells.
Background. Hyperglycemia is a known risk factor in the
pathogenesis of nephropathy, and collagen accumulation due
to an increase reactive oxygen species (ROS) has been sus-
pected to be one of the reasons for high glucose-mediated
diseases. However, molecular mechanisms that connect glucose
stimulation, oxidative stress, and collagen induction are un-
known.
Methods. We examined global changes in gene expression
patterns following high glucose stimulation by using DNA mi-
croarray technology in cultured human mesangial cells. The
expression of vitamin D3 up-regulated protein-1 (VDUP-1),
our candidate for the molecular mediator, was evaluated in
the human mesangial cells, mouse mesangial cell line, and
kidneys of diabetic mice by quantitative reverse transcription-
polymerase chain reaction (RT-PCR). Truncated VDUP-1
proteins were used to test the effects of VDUP-1 on the biosyn-
thesis of collagen in mesangial cells.
Results. Expression of VDUP-1, which was reported as an
inhibitor of thioredoxin, was induced rapidly and constantly
after exposure to high concentrations of glucose upon analysis
with DNA microarray. Overexpression of VDUP-1 gene in
cultured mesangial cells resulted in type IV collagen 1 chain
(COL4A1) mRNA induction and accumulation of type IV
collagen protein. However, induction of COL4A1 expression
was abolished with a deletion mutant of VDUP-1, which lost
thioredoxin-interacting domain. Also, streptozotocin-induced
diabetic mice were shown to overexpress VDUP-1 as well as
COL4A1.
Conclusion. VDUP-1 mediates collagen accumulation in
mesangial cells and could be the molecular mediator/marker
for fibrosis in diabetic nephropathy caused by chronic hypergly-
cemia such as diabetes.
Diabetes mellitus is implicated as the major factor
initiating development of diabetic nephropathy in hu-
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mans and in animal models of diabetes mellitus [1]. Dia-
betic nephropathy is characterized by an accumulation
of mesangial extracellular matrix and manifests as glo-
merulosclerosis [2, 3]. Elevated blood glucose levels in
diabetes promote the synthesis of extracellular matrix
proteins and inhibition of matrix turnover [1]. The accu-
mulation of matrix proteins in mesangium in diabetes in
vivo is reproduced to increase matrix proteins produc-
tion by mesangial cells grown under high glucose condi-
tions in vitro [4]. However, the molecular mechanisms
driving diabetic nephropathy in mesangial cells have not
been characterized.
Diabetic nephropathy involves structural alterations
that are characterized by development of thickened glo-
merular basement membranes and progressive accumu-
lation of extracellular matrix proteins in the glomerular
mesangium [2, 3, 5]. In kidneys of human and experimen-
tal animal models, increased renal synthesis of extracel-
lular matrix, including type IV collagen, is an early event
in diabetic nephropathy [6–8]. In mesangial cells, high
glucose stimulates the production of type IV collagen
and other extracellular matrix proteins by activating the
cellular transforming growth factor- (TGF-) system
[9]. High glucose increases the secretion of endogenous
TGF-1 [10, 11] that acts on the cells in an autocrine
fashion to stimulate the expression of extracellular ma-
trix proteins [12].
Glucose-induced oxidative stress is thought to be an
important cause of diabetic nephropathy [13, 14]. In kid-
neys with diabetic nephropathy, the levels of 8-hydroxy-
deoxyguanosine, a marker of oxidative tissue damage,
are increased [15]. In cultured mesangial cells, reactive
oxygen species (ROS) generation was demonstrated
under high glucose conditions [16], and high glucose-
induced collagen production in mesangial cells was effec-
tively prevented by antioxidants, including taurine [17]
and vitamin E [18]. It has also been reported that hydro-
gen peroxide increases gene expression of extracellular
matrix in cultured mesangial cells through activating
TGF-1 synthesis [19]. Several studies have demon-
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strated that ROS increase the synthesis of arachidonic
acid metabolites [20], platelet-activating factor [21], en-
dothelin [22], and nitric oxide [23, 24] in kidneys. These
bioactive mediators modulate cellular proliferation and
extracellular matrix synthesis in kidneys. Oxygen deriva-
tives, acting as a secondary intracellular messenger, have
been shown to activate transcription factors [25, 26],
such as nuclear factor B (NF-B) [27, 28] and activated
protein-1 (AP-1) [29].
Vitamin D3 up-regulated protein-1 (VDUP-1), origi-
nally reported as an up-regulated gene in HL-60 cells
treated with 1,25-dihydroxyvitamin D3 [30], has been
reported to interact with thioredoxin [31–35]. Thio-
redoxin acts as an antioxidant by reducing ROS and has a
role in defense against oxidative stress [25, 36]. Previous
studies showed that VDUP-1 binds to the catalytic center
of thioredoxin and inhibits the reducing activity of thio-
redoxin [31, 32, 34, 35]. Thus, VDUP-1 seems to have a
role in regulating redox state in a cell by regulating the
activity of thioredoxin. Thioredoxin has been shown to
be a direct binding protein of apoptosis signal-regulating
kinase 1 (ASK-1) and acts as a direct inhibitor of ASK-1
[37]. VDUP-1 inhibits the interaction between thio-
redoxin and ASK-1 and sensitizes cells to apoptosis [32].
In fact, it has been reported that overexpression of
VDUP-1 in NIH3T3 cells renders the cells more vulnera-
ble to hydrogen peroxide and accelerates apoptosis of
these cells during oxidative stress [32].
In this report, using a DNA chip technique, we identi-
fied that expression of VDUP-1 increased in human mes-
angial cells exposed to high glucose conditions. To assess
the role of VDUP-1 induction in mesangial cells with
high glucose, we investigated whether overexpression of
VDUP-1 modulated the expression of type IV collagen
in cultured mesangial cells. Second, we investigated
mechanisms of VDUP-1–mediated type IV collagen 1
chain (COL4A1) induction by VDUP-1 deletion mu-
tants, which were used whether they induced COL4A1
expression. And finally, we investigated its expression
in the kidneys of diabetic mice induced by streptozotocin.
METHODS
All reagents were obtained from Sigma Chemical Co.,
Ltd. (St. Louis, MO, USA) unless otherwise stated.
Primary cultured human mesangial cells
Primary cultured human mesangial cells were obtained
from Clonetics (Walkersville, MD, USA). The cells were
maintained in RPMI 1640 medium, containing 10% fetal
calf serum (FCS), 100 g/mL penicillin, and 100 g/mL
streptomycin. All culture medium were purchased from
Invitrogen Corp. (Carlsbad, CA, USA). Cells were rou-
tinely passaged with a 1:5 split and were used for experi-
ments at the seventh to ninth passages. Before the begin-
ning of experiments, cells were grown until confluent in
assay flasks with normal culture medium. Subsequently,
cells were cultured with high glucose condition for each
experimental period. During the experimental period,
to control for the effect of hyperosmolality, mesangial
cells under normal glucose condition were cultured in
medium containing 25 mmol/L l-glucose, which is an
optical isomer of d-glucose and is not metabolized in
cells. At the end of high glucose stimulation, cells were
lysed by TRIzol (Invitrogen Corp.) for investigating
gene expression. Obtained RNA was purified by RNeasy
(Qiagen GmbH, Hilden, Germany) and stored at80C
until use.
Microarray
The cDNA labeling, hybridization, and scanning were
performed as described by Affimetrix (Santa Clara, CA,
USA). DNA microarray (GeneChip MG-U74Av2, Af-
fimetrix) analysis was performed to study the gene ex-
pression profile of mesangial cells. Fold-change values
were obtained by GeneChip software and a two-fold
change was considered as a threshold for real differences
in gene expression change.
MES13 cells
The mouse mesangial cell line MES13 [38–40] was
obtained from ATCC (Manassas, VA, USA), and cul-
tured using 3:1 mixture of Dulbecco’s modified Eagle’s
medium (DMEM) and Ham’s F12 media, containing 5%
FCS, 100 ug/mL penicillin, and 100 g/mL streptomycin.
Cells were routinely passaged with a 1:10 split. MES13
cells were cultured in normal glucose (5 mmol/L) or high
glucose (30 mmol/L) conditions for 1, 2, 3, and 4 days.
At the end of each culture period, cells were lysed, and
total RNA was extracted by RNeasy (Qiagen). Obtained
RNA was dissolved in RNase-free water and stored at
80C until use.
Vitamin D3 (1,25(OH)2 vitamin D3) was dissolved in
ethanol and added to the experimental culture medium
at a final ethanol concentration of 0.1%. MES13 cells
were cultured for 24 hours in normal glucose condition
with vehicle or with various concentrations of vitamin D3.
Total RNA was extracted to measure gene expression of
VDUP-1.
For TGF--antibody experiments, MES13 cells con-
taining pIND-VDUP were incubated for 24 hours (1)
in normal glucose condition or (2) with 5 mol/L pona-
sterone A or (3) with 5 mol/L ponasterone A  20
g/mL TGF--neutralizing antibody (R&D Systems,
Minneapolis, MN, USA). At the end of incubation pe-
riod, total RNA was extracted to measure gene expres-
sion levels of VDUP-1 and COL4A1.
Quantitative polymerase chain reaction (PCR)
Total RNA was reverse-transcribed to evaluate gene
expression levels. Equal amounts of total RNA from
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each sample were converted to cDNA by TaqMAN Re-
verse Transcription Reagents (Applied Biosystems, Fos-
ter City, CA, USA, www.appliedbiosystems.com) with
random hexamer primers according to manufacturer’s
manual (Applied Biosystems). Real-time quantification
of the target genes was performed with an SYBR Green
PCR assay (Applied Biosystems) using ABI PRISM
7700 Sequence Detection System (Applied Biosystems).
The expression of glyceraldehyde-3-phosphate dehydro-
genase (GAPDH), a housekeeping gene, was measured
as an internal control for sample-to-sample variation in
reverse transcription (RT) reaction, and the extent of
degradation and recovery of RNA was monitored. As
negative controls, the same reaction was performed on
the RNA samples without RT reaction, and no PCR prod-
ucts were detected. The sequences of primers were as
follows: human VDUP-1 (AB051901), sense CACACT
TACCTTGCCAATGGC, antisense TGCGCATGTC
CCTGAGATAATA; human COL4A1 (NM001845),
sense GGTGTTGCAGGAGTGCCAG, antisense GCA
AGTCGAAATAAAACTCACCAG; mouse VDUP-1
(AF282826), sense TCTCCTAGAAGAGCAGCCTA
CAGG, anti-sense CTCGAAGCCGAACTTGTACT
CATA; and mouse COL4A1 (X06777), sense GTC
TGGCTTCTGCTGCTCTTC, antisense CCTTCACGC
CATGACAGTCA. The measurements of GAPDH ex-
pression were measured using Pre-Developed TaqMAN
Assay Reagents (Applied Biosystems). Relative quanti-
ties of target gene expressions were compared after nor-
malization to the value of GAPDH.
Overexpression of VDUP-1 in MES13 cells
An ecdysone-inducible expression system (Invitrogen
Corp.) [41] was used for VDUP-1 overexpression in
MES13 cells. To establish ecdysone-inducible system in
MES13 cells, the cells were transfected with the linear-
ized plasmid pVgRXR containing ecdysone receptor and
retinoid X receptor (RXR). The ecdysone receptor and
the RXR form a heterodimer, which binds ecdysone
response element in the presence of ponasterone A (a
synthetic analog of ecdysone). Clonal cells containing
these genes were selected by the resistance against Zeo-
cin (0.5 mg/mL). We checked for ecdysone-inducible
gene expression in these cells by transient transfection
of plasmid pIND/TOPO/lacZ, which contains -galac-
tosidase gene in the downstream of ecdysone response
element. The inducible expression of -galactosidase re-
sponding to ponasterone A, which is a potent synthetic
ecdysone analog, was tested by standard liquid O-nitro-
phenyl -galactoside assay. PCR fragment containing
the whole coding region of the mouse VDUP-1 gene was
amplified by RT-PCR. The sequences of the primers
were as follows: sense TTTTCCTCTCCGGCTTTCGT,
antisense CTTCATTTCCTGCAGCTTCA. Plasmid
pIND-VDUP was constructed by ligation of the obtained
PCR product into pIND/V5-His-TOPO vector in the
sense orientation and checked the DNA sequences. Lin-
earized pIND-VDUP was transfected to MES13 cells
expressing the heterodimeric ecdysone receptor, and
clones containing pIND-VDUP were selected by the re-
sistance to G418 (1 mg/mL). Obtained cells were treated
with 5 mol/L ponasterone A, potent ecdysone analog,
for 24 hours, and total RNA was extracted to measure
gene expression levels.
Measurement of type IV collagen protein
The amount of type IV collagen protein in the culture
medium was determined by competitive indirect enzyme-
linked immunosorbent assay (ELISA). MES13 cells con-
taining pIND-VDUP were treated with 5 mol/L pona-
sterone A for 24 hours. The culture medium was collected
and stored at 80C until use. Cells were lysed in 0.1%
sodium dodecyl sulfate (SDS) and collected to determine
the amount of cell protein. The quantities of type IV
collagen were measured by an ELISA Kit (Collagen
IV M, Exocell, Inc, Philadelphia, PA, USA). The quanti-
ties of collagen protein were normalized to the amounts
of cell protein.
VDUP-1 deletion study
Clones carrying the full-length or truncated VDUP-1
sequence were constructed as follows [33]. The full-
length and two smaller size VDUP-1 cDNA were pro-
duced by PCR. One deletion construct, DEL155, had
155 amino acid residues deleted from the first methionin,
and another construct, DEL 226, had 1-226 amino acid
residues deleted. The sequences of the PCR primers
were as follows: full-length forward ATGGTGATGTT
CAAGAAG; DEL155 forward GACCTAATGGCAC
CAGTG; DEL226 forward CAGACCAAAGTGTTC
ACT; and reverse primer for all amplicons CTTCATT
TCCTGCAGCTTCA. The cDNA sequences of first
methionin were joined to each PCR product in-frame
with the VDUP-1 protein and ligated into a plasmid
pIND. The authenticity of sequences for these constructs
was verified by DNA sequencing. These constructs were
transfected to MES13 cells expressing ecdysone recep-
tors and clones were selected by the resistance to Zeocin
and G418. Obtained clones were treated 5 mol/L po-
nasterone A for 24 hours, and total RNA was extracted
to measure gene expressions of COL4A1.
Streptozotocin-induced diabetic mouse
Ten-week-old male mice were housed in specific
pathogen-free facility and were maintained on standard
mouse chow and tap water ad libitum. The mice were
injected with a bolus injection of 185 mg/kg of streptozo-
tocin dissolved in 0.1 mmol/L citrate buffer (pH 4.5) into
the tail vain. After 4 weeks, induction of diabetes was
confirmed by measurement of the tail blood glucose level
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using the glucose oxidase method. Hyperglycemic mice
with glucose levels 300 mg/dL were used. Four weeks
after streptozotocin injection, the mice were anesthe-
tized with pentobarbital, and blood samples were taken
from the abdominal aorta. Kidneys were immediately
frozen for gene expression analysis. Total RNA was ex-
tracted from the kidneys using TRIzol, and purified by
RNeasy. RNA was dissolved in RNase-free water and
stored until use. All animal procedures complied with
NIH guidelines and were approved by the Banyu Animal
Care and Usage Committee.
Laser capture microdissection and RT-PCR
Laser capture microdissection (LCM) was performed
on a Leica AS LMD System (Leica Microsystems AG,
Wetzlar, Germany) according to a manufacturer’s man-
ual. Briefly, mice were euthanized, and the kidneys were
rapidly removed. The tissues were embedded in 22-oxa-
calcitriol compound (OCT) and immediately frozen in
dry ice-chilled hexan. Sections (8 m thick) were cut
and mounted on glass slides. The sections were fixed in
ethanol: acetic acid (19:1), rinsed with RNase-free water,
stained with 0.01% toluidine blue, rinsed with RNase-
free water, and completely dried. Approximately 350
glomeruli were collected by LCM. Total RNA from the
microdissected glomeruli was extracted using RNeasy
micro column (Qiagen). Obtained RNA samples were
checked by Bioanalyzer 2100 System (Agilent Technolo-
gies, Palo Alto, CA, USA), reverse-transcribed, and ap-
plied to TaqMan RT-PCR analysis.
Statistical analysis
Results were compared using unpaired t test. A P
value of 0.05 or less was regarded as denoting a significant
difference.
RESULTS
Induction of VDUP-1 expression in primary cultured
mesangial cells with high glucose condition
In order to evaluate genetic alterations associated with
high glucose exposure in kidney mesangial cells, we em-
ployed DNA microarray technology to analyze gene ex-
pression changes. The human mesangial cells were cul-
tured in either standard glucose conditions (5 mmol/L)
or high glucose conditions (30 mmol/L) with supplement
of FCS (10%). Cells were harvested 1, 3, and 7 days
after the high glucose exposure, and RNA was isolated.
The resulting RNA samples were subjected for DNA
microarray analysis. Oligonucleotide DNA microarray
system was used for our assay and expression of 7070
probes were monitored in these analyses. We found that
expression of S73591 was significantly induced by more
than two-fold at all experimental points (day 1, day 3, and
day 7 after culture with high glucose condition) (Table 1).
Induction of S73591 was stable at the following time
points: 3.8-fold at day 1, 8.9-fold at day 3, and 5.1-fold
increase at day 7. In fact, S73591 gene was the only gene
with constant expression changes. Other genes that were
known to alter the expression levels in mesangial cells
with high glucose exposure were as follows: 2-macro-
globulin (serpin family) [42–44], 4.4-fold at day 7; and
	-glutamylcysteine synthetase (glutathione biosynthesis)
[44], 3.9-fold at day 1. Subsequent database searches
revealed that S73591 was VDUP-1, which was a gene
originally isolated with association to oxidative stress [33].
To confirm the microarray results, VDUP-1 mRNA
expression level was reevaluated with quantitative RT-
PCR. We have confirmed that expression of VDUP-1
was increased on days 1, 3, and 7 when compared to that
of control cells (Fig. 1A). Induction rates were in good
agreement with DNA microarray results, which were
3.4-fold, 12-fold, and 6.0-fold on day 1, 3, and 7, respec-
tively. We also confirmed the expression of COL4A1
mRNA, an extracellular matrix protein that is known to
be associated with basement membrane in the human
glomeruli. The expression of COL4A1 was increased in
high glucose conditions when compared to that in the
normal glucose conditions (Fig. 1B). These results sug-
gested that our cultured condition mimics in vivo glomer-
ulosclerosis conditions as previously described by other
studies [4, 45].
The expression of VDUP-1 in MES13
VDUP-1 mRNA was induced in cultured human mes-
angial cells in high glucose conditions. Next, we evalu-
ated the effect of high glucose conditions on mouse-
cultured mesangial MES13 cells [38–40]. MES13 cells
were cultured in standard glucose (5 mmol/L) and high
glucose conditions (30 mmol/L) for 4 days, and VDUP-1
mRNA was measured at each time point (Fig. 2A). We
observed that expression of VDUP-1 was elevated at
day 1 and continuously increased until day 4. Maximum
expression of VDUP-1 was reached on day 4, which was
8.9-fold induction when compared to that during stan-
dard glucose conditions. In contrast to that of COL4A1
mRNA (Fig. 2B), induction of VDUP-1 mRNA was
more rapid and extensive, which suggested that VDUP-1
induction is mediated by direct response to the high
glucose exposure. The COL4A1 mRNA was slightly in-
duced at day 3 and reached 1.8-fold induction within 4
days. We also examined whether vitamin D3 induced
VDUP-1 expression in MES13 cells as descried in other
cell lines, and results confirmed that induction of VDUP-1
by vitamin D3 in MES13 cells (1.7-fold with 10 nmol/L
vitamin D, 1.9-fold with 1 mol/L vitamin D3 compared
to the vehicle treated).
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Table 1. Microarray analysis of gene expression in mesangial cells treated with high glucose conditions
Probe set Day 1 Day 3 Day 7 Unigene title
S73591_at 3.8 8.9 5.1 Upregulated by 1,25-dihydroxyvitamin D3
HG4557-HT4962_r_at 4.5 3.2
H72686_at 6.2 2.9 ESTs
RC_F09012_at 9.2 KIAA1073 protein
RC_F04611_at 10.4 Homosapiens clone 24538 mRNA sequence
U77604_at 12.4 Microsomal glutathione S-transferase 2
RC_AA046650_s_at 19.3 Putative nuclear protein
RC_D60700_at 17.2 ESTs
RC_D60774_f_at 14.4 ESTs
AB002292_at 8.4 KIAA0294 gene product
RC_AA599751_at 8.3 Homologous to yeast nitrogen permease
(candidate tumor suppressor)
RC_H08077_at 7.8 CGI-43 protein
U61500_at 7.6 Transmembrane protein 1
RC_AA157343_f_at 7.1 ESTs
T83496_at 6.9 Inositol polyphosphate-4-phosphatase, type I, 107kD
RC_F02561_at 6.8 ESTs
RC_AA102731_at 6.5 Myosin X
RC_D11922_at 5.9 Homosapiens mRNA; cDNA DKFZp761P1423
(from clone DKFZp761P1423)
RC_R52145_at 5.6 Homosapiens mRNA; cDNA DKFZp564N123
(from clone DKFZp564N123)
RC_AA128013_at 5.5 ESTs
RC_R68591_at 5.3 ESTs
RC_AA278670_at 5.1 Epsilon-tubulin
RC_R37027_at 5.1 KIAA0475 gene product
RC_AA609306_at 5.0 ESTs
RC_T23867_at 4.9 KIAA0804 protein
RC_AA621751_at 4.7 CGI-43 protein
RC_R06228_at 4.6 Homosapiens clone 25059 mRNA sequence
RC_Z38435_at 4.4 Ribosomal protein L21
AA070090_at 4.2 ESTs, weakly similar to JH0783 diamine
N-acetyltransferase [homosapiens]
RC_AA419461_at 4.2 ESTs
N77562_at 4.1 Hypothetical protein FLJ10209
RC_R95702_at 4.6
AA036900_at 22.2 ESTs
AA027765_at 20.0 Homosapiens clone 25036 mRNA sequence
RC_AA134138_at 7.2 Leucine aminopeptidase
D45132_at 6.9 Zinc-finger DNA-binding protein
RC_N71441_at 6.6 CGI-58 protein
RC_AA488074_at 6.1 Homosapiens mRNA; cDNA DKFZp586I1524
(from clone DKFZp586I1524)
U90546_r_at 5.8 Butyrophilin, subfamily 3, member A2
AA081209_at 5.5 Regulator of G-protein signalling 5
RC_T89848_at 4.6 ESTs
RC_F10047_at 4.5 ESTs
M11313_s_at 4.4 2-macroglobulin
U41518_at 4.2 Aquaporin 1 (channel-forming integral protein, 28kD)
M77829_s_at 4.0 Aquaporin 1 (channel-forming integral protein, 28kD)
RC_R20628_at 4.0 ESTs
RC_R48564_at 4.7 ESTs
RC_AA428366_at 5.1 Hypothetical protein FLJ10563
RC_AA235803_i_at 5.4 Cathepsin D (lysosomal aspartyl protease)
ESTs are expressed sequence tags. Genes which expression levels altered 
four-fold or four-fold are listed. Values are expressed as the fold change of high
glucose stimulated cells compared to control cells.
The effect of VDUP-1 overexpression
on COL4A1 expression
Collagen accumulation is the hallmark of glomerulo-
sclerosis, and increases of COL4A1 play a pivotal part
in this process [45]. COL4A1 induction had been demon-
strated in various in vitro models of kidney diseases such
as high glucose stimulation [46], as well as rodent models
of glomerulosclerosis, including streptozotocin-induced
diabetic mice [6, 7]. To investigate whether overexpres-
sion of VDUP-1 modulates collagen synthesis in mesan-
gial cells, we constructed an ecdysone-inducible expres-
sion system of VDUP-1 in MES13 cells (Fig. 3A). In this
system, mouse VDUP-1 gene was controlled under the
ecdysone-inducible promoter so that expression of
VDUP-1 can be regulated by the addition of ponasterone
A, a synthetic potent ligand of ecdysone receptor, which
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Fig. 1. Induction of vitamin D3 up-regulated protein-1 (VDUP-1) ex-
pression and type IV collagen 1 (COL4A1) expression in human
mesangial cells. Human mesangial cells were exposed to normal glucose
(control), and high glucose (HG) for 1, 3, and 7 days. Gene expression
was analyzed by quantitative polymerase chain reaction (PCR) with
corresponding the expression of glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) as an internal control for loading. (A ) The expres-
sions of VDUP-1 mRNA. (B ) The expression levels of COL4A1
mRNA. The mean  SD (N  3) of obtained values are shown with
the relative ratio in control cells assigned a value of 1. *P  0.05 vs.
control; †P  0.01 vs. control.
upon the ligand binding, stimulates VDUP-1 expression.
Plasmids containing ecdysone receptor and ecdysone-
inducible VDUP-1 were sequentially transfected to
MES13 cells and clones containing both plasmids were
selected by resistance to Zeocin and G418. We checked
the ecdysone induction in each clone by transient trans-
fection of -galactosidase, which was cloned under ecdy-
sone-inducible promoter, and cells with confirmed induc-
tion of -galactosidase by addition of ponasterone A
were used in further analysis. Expression levels of
VDUP-1 and COL4A1 were evaluated by the quantita-
tive TaqMAN PCR. Figure 3 shows that VDUP-1 ex-
pression was induced about three-fold upon ponasterone
stimulation (Fig. 3B), and expression of COL4A1 was
induced about 1.8-fold (Fig. 3C). Cells, which were trans-
fected only with ecdysone receptor, did not induce
VDUP-1 and COL4A1 expression. In addition, we evalu-
ated the accumulation of type IV collagen protein by
ELISA, which confirmed the 2.7-fold accumulation of
type IV collagen protein (Fig. 3D). These results indi-
cated that VDUP-1 overexpression induced COL4A1
expression in MES13 cells and suggested VDUP-1 lo-
cates upstream of a COL4A1 expression regulation
mechanism.
Fig. 2. Induction of vitamin D3 up-regulated protein-1 (VDUP-1) ex-
pression and type IV collagen 1 (COL4A1) expression in MES13 cells.
MES13 cells were incubated for 4 days in normal glucose or high glucose
condition. Gene expressions were analyzed by quantitative polymerase
chain reaction (PCR) with corresponding glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) as an internal control for loading. (A ) Ex-
pression levels of VDUP-1 mRNA. (B ) Expression levels of COL4A1
mRNA. The values are indicated with the relative ratio to each gene
expression in the samples at day 0 assigned a value of 1. Each point
represents the mean  SD (N  4). *P  0.05 vs. control; †P  0.01
vs. control.
The effect of truncated VDUP-1 on
the COL4A1 expression
In an attempt to assess functions of VDUP-1 in up-
regulation of COL4A1 mRNA directly, we constructed
a series of deletions in VDUP-1 molecule [33], and the
effects of these deletions on the expression of COL4A1
mRNA were investigated using the same ecdysone-
inducible expression system. Two deletion constructs are
illustrated in Figure 4A; DEL155 had a deletion of the
first methionin to codon 155, DEL226 had a deletion of
the 1-226 amino acid residues. These truncated VDUP-1
constructs were transfected to ecdysone receptor-con-
taining MES13 cells, and expressions of VDUP-1 or its
truncated forms was stimulated with 5 M of ponaster-
one. Expression of COL4A1 mRNA was observed in
both clones containing either full length VDUP-1 or
DEL115 (Fig. 4B), whereas the VDUP-1 construct with
226 amino acids deletion (DEL226) failed to stimulate
COL4A1 expression even when they retained the up-
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Fig. 3. Up-regulation of type IV collagen 1
(COL4A1) expression by vitamin D3 up-regu-
lated protein-1 (VDUP-1) in MES13 cells. (A )
The scheme of ecdysone-inducible expression
system. Abbreviations are: EcR, ecdysione re-
ceptor; RXR, retinoid X receptor; P, ponaster-
one A (synthetic ecdysone analog); E/GRE,
ecdysone response element. (B ) The induc-
tion of VDUP-1 expression in MES13 cells
with the ecdysone-inducible expression sys-
tem. Cells were incubated for 24 hours in nor-
mal glucose condition with () or without
() ponasterone A. Gene expressions were
analyzed by quantitative PCR with corre-
sponding that of GAPDH as an internal con-
trol. The values are indicated with the relative
ratio to the expression of VDUP-1 in the con-
dition without ponasterone A assigned a value
of 1. (C ) The expression of COL4A1 mRNA
in MES13 cells. The values are indicated with
the relative ratio to the expression of COL4A1
mRNA in the condition without ponasterone
A assigned a value of 1. (D ) The accumulation
of type IV collagen protein in the culture me-
dium. Cells containing pIND-VDUP were in-
cubated for 24 h in normal glucose condition
with () or without () ponasterone A. The
quantities of type IV collagen contained in
the media at the end of incubation were de-
termined by enzyme-linked immunosorbent
assay (ELISA). Each point represents the
mean  SD (N  3). *P  0.05 vs. without
ponasterone A; †P  0.01 vs. without ponast-
erone A.
regulation of the VDUP-1 (Fig. 4B). These results indi-
cated that the critical domain for COL4A1 induction
resides in the amino acids residues 156-226 and that
DEL226 lost the up-regulation activity of COL4A1 ex-
pression.
The expression of VDUP-1 in the kidneys of
streptozotocin-induced diabetic mice
Following in vitro observations, we studied the expres-
sion of VDUP-1 and COL4A1 in the diabetic kidney
in vivo model. The streptozotocin-induced nephropathy
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Fig. 4. Effects of truncated vitamin D3 up-
regulated protein-1 (VDUP-1) on expression
levels of type IV collagen 1 (COL4A1)
in MES13. (A ) Constructs of truncated
VDUP-1. The numbers above the closed bars
indicate the amino acid numbers of VDUP-1
protein. Each construct was transfected into
MES13 cells with ecdysone-inducible systems,
and the expressions of transfected genes were
induced by ponasterone A. (B ) The gene
expressions of VDUP-1 and COL4A1 in the
cells (upper, full-length transfected; middle,
DEL155 transfected; bottom, DEL226 trans-
fected). Cells were treated with () or without
() ponasterone A for 24 hours. Left graphs
show the expression levels of VDUP-1, and
right graphs show the expression levels of
COL4A1. The values of gene expressions are
indicated with the relative ratio to each gene
expression in each clone without ponasterone
A assigned a value of 1. Each point represents
the mean SD (N 3). †P 0.01 vs. control.
model is a well-established in vivo model of diabetic
nephropathy [6, 47], and several reports concluded that
accumulation of collagen is important for pathogenesis
of this model [6]. Also, in this streptozotocin-induced
model, blood glucose was reported to be elevated [47].
Therefore, we chose streptozotocin-induced diabetic
mice to evaluate the expression level of VDUP-1 mRNA
in the kidneys. In our streptozotocin-induced mouse
model, blood glucose levels were elevated after 28 days
from the streptozotocin injection when compared to sa-
line injection (Fig. 5A). The significant increase in blood
glucose level suggested that mice were in the diabetic
condition and relevant to elucidate VDUP-1 functions.
Mice were sacrificed at 28 days, and mRNA levels were
measured by quantitative TaqMAN PCR. The VDUP-1
mRNA seemed to be up-regulated in the kidneys of
diabetic mice, and COL4A1 mRNA was significantly
higher in the streptozotocin-treated diabetic mice than
in control mice (Fig. 5B). We further confirmed that
increased in VDUP-1 mRNA expression in glomeruli
by laser capture microdissection from isolated glomeruli
(Fig. 5C). These results imply that in vitro observations
of VDUP-1-regulated COL4A1 expression could be
translated to in vivo models of diabetic glomerulosclero-
sis, and pharmaceutical intervention of this process could
lead to improvements in this pathologic condition.
DISCUSSION
In the present study, we evaluated mRNA expression
changes associated with exposure to high glucose in cul-
tured human primary mesangial cells. Upon analysis with
DNA microarray, we have found that expression of
VDUP-1, a vitamin D3 up-regulated protein-1, was
induced rapidly and constantly after exposure to high
concentrations of glucose. Overexpression of VDUP-1
mRNA in MES13 mesangial cells revealed that COL4A1
mRNA was induced by the expression of VDUP-1; how-
ever, the induction of COL4A1 expression was abolished
in MES13 cells, which overexpressed a deletion mutant
of VDUP-1. Streptozotocin-induced diabetic mice were
shown to overexpress VDUP-1 and COL4A1. These re-
sults strongly indicated that VDUP-1 mediated collagen
accumulation both in vitro and in vivo in mesangial cells
and could be the molecular mechanism/marker for glo-
merulosclerosis caused by chronic hyperglycemia such
as diabetes.
To our surprise, the expression patterns of only a few
genes were changed by high glucose stimulation. A total
of 173 genes showed increased expression after glucose
exposure, and 82 genes showed two-fold decreases in
gene expression. Several proteins associated with extra-
cellular matrix have also changed their expression pat-
terns. Expression levels of tenascin C [48, 49] and entac-
tin [50] were increased. However, relative changes in
matrix protein mRNAs were small when compared to
those reported in other published studies, and expression
changes greater than two-fold were not detected in other
matrix proteins. We chose to use mild cell culture condi-
tions, which included serum and standard glucose in con-
trol cells, and these conditions may have contributed
to the smaller changes after glucose stimulation. DNA
microarray results were also confirmed by the other
measurement of mRNA such as quantitative RT-PCR
methods.
There are several observations that may suggest the
mechanisms of VDUP-1 induction after high glucose
exposure. NF-B is a transcription factor that regulates
the variety of gene expressions [25] and is known to be
one of the acute transcription factors that are induced
by high glucose [28]. NF-B mediates its transcriptional
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Fig. 5. Vitamin D3 up-regulated protein-1 (VDUP-1) expression in
streptozotocin-induced diabetic mice. (A ) Blood glucose concentrations
of streptozotocin-induced diabetic mice. () indicates blood glucose
levels of control mice and () indicates that of diabetic mice. (B ) The
expression levels of type IV collagen 1 (COL4A1) and VDUP-1 in
kidneys of diabetic mice. The gene expression levels were analyzed by
quantitative reverse transcription-polymerase chain reaction (RT-PCR)
with corresponding that of glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) as an internal control for loading. Left graph shows the
levels of COL4A1 mRNA, and right graph shows the levels of VDUP-1
mRNA. The values are indicated with the relative ratio to each gene
expression in control mice assigned a value of 1. Each point represents
the mean  SE (N  4). (C ) The gene expression levels of VDUP-1
in glomeruli of diabetic mice. The glomeruli were collected by laser
capture microdissection (LCM), and the expression levels of VDUP-1
were analyzed by quantitative RT-PCR. The values are indicated with
the relative ratio to the gene expression in control mice assigned a
value of 1. Each point represents the mean  SE (N  3). *P  0.05
vs. control; †P  0.01 vs. control.
activation via binding to the nucleotide sequence, and
this sequence is known to be located within the promoter
region of VDUP-1 [51]. Overexpression of thioredoxin
was reported to down-regulate NF-B in HeLa cells
[52], which could be the mechanisms to maintain high
VDUP-1 expression in reduced thioredoxin activities
such as glucose exposure.
Oxidative stress has been implicated in the pathogene-
sis of tissue fibrosis [19], and the regulation of cellular
antioxidant systems is controlled by the activities of re-
dox balance systems, including the thioredoxin system.
Thioredoxin acts as an antioxidant by reducing ROS
through an interaction with the redox-active center of
thioredoxin [36, 53] and protects cells against hydrogen
peroxide-induced cytotoxicity [36]. Thioredoxin partici-
pates in many thiol-dependent cellular reductive pro-
cesses, including signal-transduction and regulation of
the activity of transcription factors [25, 26]. VDUP-1 has
been reported as an endogenous inhibitor of thioredoxin
[31, 32], and the redox-active site of thioredoxin mediates
the interaction with VDUP-1 [33], suggesting that the
interaction may be an important regulatory mechanism
of cellular redox processes. We found that expression of
VDUP-1 is induced in the cells exposed to high glucose
conditions, and similar observation was reported re-
cently in rat-1 fibroblasts [54]. It is possible that the
antioxidative response caused by high glucose exposure
is induced by the rapid increase in VDUP-1 message and
resulted changes in thioredoxin activity as an antioxi-
dant. This is in good agreement with our deletion studies
of VDUP-1. When we introduced the deletion of 1-226
amino acids in VDUP-1, the effects of COL4A1 mRNA
induction were abolished; while mRNA induction was
not affected by deletion of amino acids 1-155. The sug-
gested critical domain for collagen induction resides be-
tween amino acids residues 156 and 226. This region
coincides with the domain of VDUP-1 and thioredoxin
interaction. Since the same region of VDUP-1 is respon-
sible for both the up-regulation of COL4A1 and thio-
redoxin interaction, the induction of COL4A1 mRNA
could be associated with oxidative response of VDUP-1.
Induction of COL4A1 message by oxidative stress has
been previously described [19, 55]. High glucose stress-
induced redox imbalance may cause dysregulation of
collagen biosynthesis, which contributes to a variety of
pathologic processes, including the kidney fibrogenic
process in diabetic nephropathy [13, 17, 18].
Induction of TGF- and activation of TGF- pathway
are well-documented molecular events that occur during
glomerulosclerosis both in vitro [12, 47, 56] and in vivo
[10, 47]. It has been reported that high glucose conditions
in cultured mesangial cells induced TGF- pathway [56],
and also hydrogen peroxide was reported to increase
extracellular matrix mRNA through TGF- cascade in
mesangial cells [19]. In fact, in our inducible VDUP-1
expression system, induction of type IV collagen expres-
sion was suppressed significantly by the additional of
anti-TGF- antibody (Fig. 6 A and B). Hence, this obser-
vation confirmed that high glucose conditions lead to
the VDUP-1 mRNA increase, which mediates type IV
collagen expression, at least partially, through TGF-
cascade. Direct interaction between collagen peptide
(pro-1 type I collagen) and reduced form of thioredoxin
was recently reported, suggesting a possibility that as-
sembly of type I collagen protein is under the regulation
of thioredoxin-dependent redox control [57]. Although
interaction of thioredoxin and type IV collagen remained
to be elucidated, induction of VDUP-1 may have direct
effects in type IV collagen assembly and accumulation.
It was reported that a potent vitamin D3 analog in-
creases expression levels of TGF- type II receptor and
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Fig. 6. Effect of transforming growth factor- (TGF- ) blockade on
vitamin D3 up-regulated protein-1 (VDUP-1)-induced type IV collagen
1 (COL4A1) expression. MES13 cells containing pIND-VDUP were
incubated for 24 hours in normal glucose condition (), with 5 mol/L
ponasterone A (), or with 5 mol/L ponasterone A 20 g/mL TGF-
-neutralizing antibody ( ). (A ) The expression of VDUP-1 mRNA
in MES13 cells. (B ) The expression of COL4A1 mRNA in MES13
cells. The values are indicated with the relative ratio to the expression
of each gene in the condition without ponasterone A and anti-TGF-
antibody assigned a value of 1. Each point represents the mean  SD
(N 3). *P 0.05 vs. normal condition; †P 0.01 vs. normal condition;
‡P  0.05 vs. ponasterone A without anti-TGF-  antibody.
type IV collagen in mesangial cells [58], and MES13
cells induced VDUP-1 expression by vitamin D3 in our
experiment. Since beneficial effects of a vitamin D3 ana-
log in rat anti-Thy 1 glomerulonephritis was documented
[59], it could be interesting to examine the expression
levels of VDUP-1 in such models.
We also confirmed that overexpression of VDUP-1
occurs in the streptozotocin-induced diabetic nephropa-
thy model. The expression of VDUP-1 was significantly
increased in kidneys of diabetic mice when compared to
saline injected control mice, and expression of COL4A1
was increased. These results suggested that exposure to
high glucose condition in vivo also caused up-regulation
of VDUP-1 and COL4A1. However, our current study
did not address the relationship among disease progres-
sion, VDUP-1 expression, and fibrosis; it is interesting to
investigate the correlations between severity of glycemia
and VDUP-1 expression in streptozotocin-induced dia-
betic models.
CONCLUSION
We have identified a molecular mediator of collagen
induction, VDUP-1, in vitro, and in vivo in streptozo-
tocin-induced diabetic nephropathy models, by DNA
microarray technology. Overexpression of VDUP-1 in
mesangial cells directly influenced the level of COL4A1
mRNA in cultured mesangial cells, and deletion of thio-
redoxin-interacting domain abolished VDUP-1 induced
COL4A1 expression. These data, together with previous
works, indicated that VDUP-1 contributes to the devel-
opment of diabetic nephropathy. Further works that de-
cipher molecular pathways from VDUP-1 to COL4A1
will give us more insight into the role of hyperglycemia
and oxidative stress in development of the fibrosis of
diabetic nephropathy.
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